Toshiyuki Sakaeda - Concepedia

Author

Toshiyuki Sakaeda

Also Known As

Sakaeda, Toshiyuki, T SAKAEDA, T. Sakaeda, Toshiyuki SAKAEDA, Toshiyuki SAKAEDA(ne KAKUTANI), Toshiyuki Sakaeda, Toshiyuki Sakaeda (Nee Katutani), Toshiyuki Sakaeda (ne Kakutani), Toshiyuki Sakaeda (nee Kakutani)

249

Publications

8.7K

Citations

H-Index

178

Concepts

All Affiliations

Kobe University Hospital Kobe University Kyoto Pharmaceutical University Kyoto University Shionogi (Japan)

About

Toshiyuki Sakaeda is an author at Kobe University Hospital specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	83	3K
2	Health Sciences	9	9	238
3	Natural Sciences	9	9	650
4	Social Sciences	6	6	195
5	Engineering	4	4	178

Toshiyuki Sakaeda

162

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects Toshiyuki Sakaeda, Tsutomu Nakamura, Masanori Horinouchi, Pharmaceutical Research	2001	320
Effect of the mutation (C3435T) at exon 26 of the <i>MDR1</i> gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects Tsutomu Nakamura, Toshiyuki Sakaeda, Masanori Horinouchi, Clinical Pharmacology & Therapeutics Duodenal EnterocytesMedicineGeneticsNatural SciencesExon 26	2002	260
Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas Tsutomu Nakamura, Toshiyuki Sakaeda, Nobuko Ohmoto, Drug Metabolism and Disposition	2002	134
Human Group IIA Secretory Phospholipase A2 Induces Neuronal Cell Death via Apoptosis Tatsurou Yagami, Keiichi Ueda, Kenji Asakura, Molecular Pharmacology	2002	131
Effects of Polymorphisms of MDR1, MRP1, and MRP2 Genes on Their mRNA Expression Levels in Duodenal Enterocytes of Healthy Japanese Subjects. Yuka Moriya, Tsutomu Nakamura, Masanori Horinouchi, Biological and Pharmaceutical Bulletin	2002	128
Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of Digoxin Masanori Horinouchi, Toshiyuki Sakaeda, Tsutomu Nakamura, Pharmaceutical Research	2002	126
CYP2C19 Genotype and Pharmacokinetics of Three Proton Pump Inhibitors in Healthy Subjects Toshiyuki Sakai, Nobuo Aoyama, Tomoko Kita, Pharmaceutical Research	2001	115
Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma Hiroyuki Imanishi, Noboru Okamura, Mariko Yagi, Journal of Human Genetics Hematological MalignancyAdverse EventsGenetic PolymorphismsMedicineMixed-phenotype Acute Leukemia	2006	115
Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy Yasuhiro Takeshima, Mariko Yagi, Hiroko Wada, Pediatric Research Exon SkippingAntisense Oligonucleotide ResultsSkeletal MuscleDuchenne Muscular DystrophyMedicine	2006	100
Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs Toshiyuki Sakaeda, Koichi Iwaki, Mikio Kakumoto, Journal of Pharmacy and Pharmacology Cytochrome P450 3A4Drug Resistance AnalysisAntifungal AgentBiochemistryAntifungal Agents	2005	98

Page 1